miR-200cとmiR-429のアップレギュレーションは,クリア細胞腎臓細胞癌の静脈腫瘍血栓における上皮状態への逆転を示唆する
Tanja Čugura1, Emanuela Boštjančič1, Jera Jeruc1
1Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
International journal of molecular sciences
|August 28, 2025
まとめ
この研究では,腎臓細胞癌 (RCC) の静脈侵入における上皮細胞- 介質細胞移行 (EMT) を調査した. 結果は,静脈腫瘍のEMTの潜在的逆転を示唆し,上皮状態へのシフトを示唆しています.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 研究
背景:
- 腎臓細胞癌 (RCC) は,静脈で腫瘍の血栓を頻繁に形成しますが,そのメカニズムは不明です.
- Epithelial- mesenchymal transition (EMT) はがんの進行と関連しているが,RCCの静脈侵入におけるその役割は完全に理解されていない.
研究 の 目的:
- 透明な細胞RCC内の静脈侵入におけるEMTの関与を調査する.
- 異なる腫瘍領域と静脈腫瘍トロンビにおける重要なEMTマーカーの発現を分析する.
主な方法:
- 定量PCR (qPCR) は,miR-200ファミリー,miR-205,SNAI1/ 2,TWIST1,ZEB2,CDH1を含むEMTマーカーの発現を分析するために使用されました.
- 免疫ヒストケミストリーは,E-カデリン,N-カデリン,ZEB2発現を評価した.
- 発現レベルは,腫瘍の中心,腫瘍周辺,静脈腫瘍の血栓,および非新形成性腎臓組織を比較した.
主要な成果:
- 腫瘍以外の組織と比較して,すべての腫瘍領域で miR-200ファミリーがダウンレギュレーションされた.
- miR- 200cとmiR- 429は,腫瘍中心部 (TC) と比較して静脈腫瘍栓 (VTT) で上位調節された.
- CDH1は腫瘍周辺 (TP) と非腫瘍組織でダウンレギュレーションされ,SNAI2はすべての腫瘍領域でダウンレギュレーションされた.
結論:
- 異なるccRCC領域の間には異なる分子シグネチャーが存在する.
- VTTにおける特定のmiRNAの上昇とCDH1との相関は,EMTの潜在的逆転を示唆する.
- この逆転は,静脈腫瘍内のより上皮細胞状態への潜在的なシフトを示しています.
関連する概念動画
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


